ArticleScientific reports2024

Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts.

Farhana Jahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.